U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry RACEMIC
Molecular Formula C9H13NO3.ClH
Molecular Weight 219.665
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of RACEPINEPHRINE HYDROCHLORIDE

SMILES

Cl.CNCC(O)C1=CC(O)=C(O)C=C1

InChI

InChIKey=ATADHKWKHYVBTJ-UHFFFAOYSA-N
InChI=1S/C9H13NO3.ClH/c1-10-5-9(13)6-2-3-7(11)8(12)4-6;/h2-4,9-13H,5H2,1H3;1H

HIDE SMILES / InChI

Molecular Formula C9H13NO3
Molecular Weight 183.2044
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Racepinephrine or racemic epinephrine is a mixture of levo and dextro isomers of epinephrine act as a nonselective agonist at adrenergic receptors. It is a bronchodilator used in the temporary relief of mild symptoms of intermittent asthma including wheezing, shortness of breath. Inhaled racepinephrine became available in September 2012 as a nonprescription treatment for bronchospasm based on a 1986 US Food and Drug Administration rule. Besides, racemic epinephrine relieves respiratory distress in hospitalized infants with bronchiolitis and is safe but does not abbreviate hospital stay. Morbidity associated with bronchiolitis as identified by parents persists for at least one week after hospital discharge in most infants.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
Unknown

Approved Use

For temporary relief of mild symptoms of intermittent asthma: wheezing, tightness of chest, shortness of breath
Palliative
Unknown

Approved Use

Unknown
Doses

Doses

DosePopulationAdverse events​
50 mg single, oral
Overdose
Dose: 50 mg
Route: oral
Route: single
Dose: 50 mg
Sources:
unknown, 2 years
Health Status: unknown
Age Group: 2 years
Sex: M
Sources:
Disc. AE: Hypertension, Tachycardia...
AEs leading to
discontinuation/dose reduction:
Hypertension (5.4%)
Tachycardia (5.4%)
Sources:
AEs

AEs

AESignificanceDosePopulation
Hypertension 5.4%
Disc. AE
50 mg single, oral
Overdose
Dose: 50 mg
Route: oral
Route: single
Dose: 50 mg
Sources:
unknown, 2 years
Health Status: unknown
Age Group: 2 years
Sex: M
Sources:
Tachycardia 5.4%
Disc. AE
50 mg single, oral
Overdose
Dose: 50 mg
Route: oral
Route: single
Dose: 50 mg
Sources:
unknown, 2 years
Health Status: unknown
Age Group: 2 years
Sex: M
Sources:
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Structural basis of beta-adrenergic receptor subtype specificity studied with chimeric beta 1/beta 2-adrenergic receptors.
1988 Dec
Structural and conformational features determining selective signal transduction in the beta 3-adrenergic receptor.
1993 Dec
Carazolol: a potent, selective beta 3-adrenoceptor agonist.
1995 Nov 30
Ligand efficacy and potency at recombinant alpha2 adrenergic receptors: agonist-mediated [35S]GTPgammaS binding.
1998 Apr 1
The effect of methylene blue on the hemodynamic changes during ischemia reperfusion injury in orthotopic liver transplantation.
2002 Apr
Epinephrine as a mediator of pulmonary neutrophil sequestration.
2002 Jul
The efficacy of hemodynamic and T-wave criteria for detecting intravascular injection of epinephrine test dose in propofol-anesthetized adults.
2002 Mar
Exercise-induced changes in plasma composition increase erythrocyte Na+,K+-ATPase, but not Na+-K+-2Cl- cotransporter, activity to stimulate net and unidirectional K+ transport in humans.
2003 Dec 15
Comparative pharmacology of human beta-adrenergic receptor subtypes--characterization of stably transfected receptors in CHO cells.
2004 Feb
Catecholamines potentiate the effect of thyroid hormone on intestinal absorption of glucose in the rat.
2005 Jun
[Experimental studies of rhizoma Astilbes chinensis on its effects in abirritation, blood activation, cough relieving and sputum elimination].
2006 Dec
Strategies for enantioseparations of catecholamines and structurally related compounds by capillary zone electrophoresis using sulfated beta-cyclodextrins as chiral selectors.
2006 Sep
Extracellular signal-regulated kinase 1/2-mediated transcriptional regulation of G-protein-coupled receptor kinase 3 expression in neuronal cells.
2007 Apr
More PKA independent beta-adrenergic signalling via cAMP: is Rap1-mediated glucose uptake in vascular smooth cells physiologically important?
2007 Jun
Stereospecificity of mushroom tyrosinase immobilized on a chiral and a nonchiral support.
2007 May 30
End-column chemiluminescence detection for pressurized capillary electrochromatographic analysis of norepinephrine and epinephrine.
2007 Nov 2
Neuronal nitric oxide synthase gene inactivation reduces the expression of vasopressin in the hypothalamic paraventricular nucleus and of catecholamine biosynthetic enzymes in the adrenal gland of the mouse.
2008 Jan
Adrenaline-induced chronic ocular hypertension in adult rabbits.
2009 Apr
Characteristics and outcome of cardiopulmonary resuscitation in hospitalised African children.
2009 Jan
Enhanced voltammetric detection of epinephrine at a carbon nanotube/nafion composite electrode in the presence of ascorbic acid.
2009 Nov
Patents

Sample Use Guides

Bronchiolitis: 0,1ml<5kg, 0,15ml 5-6,9kg, 0,20ml 7-9,9kg, 0,25ml >10kg of racemic adrenaline (racepinephrine) 20mg/ml diluted in 2ml NaCl. Maximum 12 inhalations/24 hours
Route of Administration: Other
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:28:37 GMT 2025
Edited
by admin
on Mon Mar 31 18:28:37 GMT 2025
Record UNII
336096P2WE
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
RACEPINEPHRINE HYDROCHLORIDE
USP  
Common Name English
EPINEPHRINE,RACEMIC HYDROCHLORIDE
VANDF  
Preferred Name English
EPINEPHRINE DL-FORM HYDROCHLORIDE
MI  
Common Name English
EPINEPHRINE HYDROCHLORIDE, DL-
Common Name English
EPINEPHRINE,RACEMIC HYDROCHLORIDE [VANDF]
Common Name English
RACEPINEPHRINE HYDROCHLORIDE [USP-RS]
Common Name English
RACEPINEFRINE HYDROCHLORIDE
WHO-DD  
Common Name English
Racepinefrine hydrochloride [WHO-DD]
Common Name English
RACEPINEPHRINE HYDROCHLORIDE [USP MONOGRAPH]
Common Name English
EPINEPHRINE DL-FORM HYDROCHLORIDE [MI]
Common Name English
ADRENALINE HYDROCHLORIDE, DL-
Common Name English
RACEPINEPHRINE HCL
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C319
Created by admin on Mon Mar 31 18:28:37 GMT 2025 , Edited by admin on Mon Mar 31 18:28:37 GMT 2025
CFR 21 CFR 341.16
Created by admin on Mon Mar 31 18:28:37 GMT 2025 , Edited by admin on Mon Mar 31 18:28:37 GMT 2025
Code System Code Type Description
MERCK INDEX
m4944
Created by admin on Mon Mar 31 18:28:37 GMT 2025 , Edited by admin on Mon Mar 31 18:28:37 GMT 2025
PRIMARY Merck Index
NCI_THESAURUS
C73826
Created by admin on Mon Mar 31 18:28:37 GMT 2025 , Edited by admin on Mon Mar 31 18:28:37 GMT 2025
PRIMARY
EPA CompTox
DTXSID9057717
Created by admin on Mon Mar 31 18:28:37 GMT 2025 , Edited by admin on Mon Mar 31 18:28:37 GMT 2025
PRIMARY
ECHA (EC/EINECS)
206-346-0
Created by admin on Mon Mar 31 18:28:37 GMT 2025 , Edited by admin on Mon Mar 31 18:28:37 GMT 2025
PRIMARY
CAS
329-63-5
Created by admin on Mon Mar 31 18:28:37 GMT 2025 , Edited by admin on Mon Mar 31 18:28:37 GMT 2025
PRIMARY
ChEMBL
CHEMBL1740
Created by admin on Mon Mar 31 18:28:37 GMT 2025 , Edited by admin on Mon Mar 31 18:28:37 GMT 2025
PRIMARY
FDA UNII
336096P2WE
Created by admin on Mon Mar 31 18:28:37 GMT 2025 , Edited by admin on Mon Mar 31 18:28:37 GMT 2025
PRIMARY
DAILYMED
336096P2WE
Created by admin on Mon Mar 31 18:28:37 GMT 2025 , Edited by admin on Mon Mar 31 18:28:37 GMT 2025
PRIMARY
DRUG BANK
DBSALT001518
Created by admin on Mon Mar 31 18:28:37 GMT 2025 , Edited by admin on Mon Mar 31 18:28:37 GMT 2025
PRIMARY
PUBCHEM
5924
Created by admin on Mon Mar 31 18:28:37 GMT 2025 , Edited by admin on Mon Mar 31 18:28:37 GMT 2025
PRIMARY
SMS_ID
100000127817
Created by admin on Mon Mar 31 18:28:37 GMT 2025 , Edited by admin on Mon Mar 31 18:28:37 GMT 2025
PRIMARY
RXCUI
314610
Created by admin on Mon Mar 31 18:28:37 GMT 2025 , Edited by admin on Mon Mar 31 18:28:37 GMT 2025
PRIMARY RxNorm
EVMPD
SUB33967
Created by admin on Mon Mar 31 18:28:37 GMT 2025 , Edited by admin on Mon Mar 31 18:28:37 GMT 2025
PRIMARY
RS_ITEM_NUM
1598097
Created by admin on Mon Mar 31 18:28:37 GMT 2025 , Edited by admin on Mon Mar 31 18:28:37 GMT 2025
PRIMARY
Related Record Type Details
ENANTIOMER -> RACEMATE
PARENT -> SALT/SOLVATE
PARENT -> SALT/SOLVATE
ENANTIOMER -> RACEMATE
Related Record Type Details
IMPURITY -> PARENT
Related Record Type Details
ACTIVE MOIETY